
Bianca Silva
Digital Producer at Newsday
Digital Producer @newsday. Former secretary @NAHJ_NYC. Work: @FortuneMagazine @HuffPost @TIME @BleacherReport @businessinsider @BBC. Mets fan, sports nerd.
Articles
-
2 weeks ago |
portal1.fmu.br | Bianca Silva
Alunos, Eventos, FMU 07/04/2025 Se você é criativo, conectado e tem paixão por redes sociais, chegou a sua chance de brilhar! As inscrições para o Squad Digital da FMU estão abertas, e essa é a sua oportunidade de se tornar um embaixador da marca, criar conteúdos autênticos e ainda ganhar diversos benefícios. Por que participar?
-
2 months ago |
ibw21.org | Bianca Silva
Overview:Originally published on Feb. 3, 2019 in The Haitian Times, this article explores the life of Mary Ellen Pleasant, a Haitian-descended entrepreneur and abolitionist who used her wealth and influence to fight for civil rights in 19th-century America. Despite backlash, she remained a powerful force for justice. By Bianca Silva —Few women in the 1800s captivated society with as much ambition and cleverness as Mary Ellen Pleasant.
-
Jul 2, 2024 |
biorxiv.org | Vinicius Barbosa |Bianca Silva |Erica Hasui
AbstractSome birds exhibit the behavior of nest parasitism, which involves laying their eggs in the nests of other species to be incubated and cared for by the adoptive parents. Among all the studies conducted on this subject, there is a gap regarding the nest type of nest parasites and their hosts.
-
Jun 21, 2024 |
newsbreak.com | Bianca Silva
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments.
-
May 2, 2024 |
biorxiv.org | Bianca Silva |Frédéric Baron |Grégory Ehx |Charline Faville
AbstractAllogeneic hematopoietic cell transplantation (allo-HCT) is the main therapeutic approach for patients with high-risk acute myeloid leukemia (AML), but the rate of relapse remains high and is associated with poor outcomes. Discovering new approaches to maximize the graft-versus-leukemia (GVL) effects while mitigating graft-versus-host disease (GVHD) should therefore be pursued.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 587
- Tweets
- 1K
- DMs Open
- No